6th Annual Vaccine World Asia Congress 2024

Due to increasing healthcare expenditure, advancing vaccine technology, and rising demand for preventive vaccines, the Asia-Pacific preventive vaccines market will rise by 12.89% annually with a total addressable market cap of $97.2 billion between 2020 and 2026.

Vaccine World Asia Congress 2024 is the only vaccine-focused platform in Asia. We bring together global partners and regional stakeholders to leverage partnership opportunities, learn about the latest technological advancements and spearhead scientific innovation. The event will play host to Big Pharmas, International Biopharma, Asian Biopharma, Academic & Research Institutes, Fill Finish Service Providers, Regulatory Authorities, NGOs, CMO/CDMOs, Solution Providers, and Technocrats.

Together with Vaccine World Asia, we have our Asia-Pacific Vaccine Excellence Awards 2024. If Asia’s vaccine business matters to you, then Vaccine World Asia Congress 2024 is the place to be!